Ann: March 2014 NEWSLETTER , page-55

POH association with MZ would indicate their concern on future funding doubting any significant cash from Themis &/or perhaps Mylan . It would also indicate a low degree of formality in talks with pharma' at this time . Any large pharma with the hook in would be prepared to trade expertise & research funding to be at the queue head if impressed by the opiod patch developments . Its just lunch money for pharma , the usual industry punt & its not there . On a more positive note I see MZ encourages the preferred playez business model no doubt reconizing science is about evidence ! Needless to say POH still appears in the cash chasing business .